Highlights from the 2021 ASCO Annual Meeting

Experts in cancer research, treatment, and patient care from around the nation gathered virtually June 4-8 for ASCO’s 2021 National Meeting.
The program contained numerous groundbreaking studies, including:

  • 80% of female oncologists experience sexual harassment at work from co-workers and superiors, as well as from patients and families. This affects burnout, satisfaction, and turnover. Learn more
  • Lutetium-177–PSMA-617 represents a new treatment for prostate cancer. Learn more
  • In cases of advanced cervical cancers already treated with chemotherapy and radiation, less treatment may be better than more. Learn more
  • A new treatment is available for KRAS G12C mutated advanced lung cancer, which previously was considered “undruggable”. Other tumor types also have KRAS G12C mutations and may benefit from this treatment, as well. Learn more
  • Several presentations addressed the need to improve disparate patient outcomes, as well as clinical trial and workplace diversity. These represented the meeting’s overall theme set forth by ASCO President Dr. Lori Pierce. Learn more